biovisionK702-200CYP3A inhibitor screening kit, CYP3A4 inhibitor kit, CYP inhibitor screening, screen cytochrome P450 inhibitors, study Cytochrome P450 3A4 inhibitors, characterize CYP inhibitors, CYP3A4 inhibitor, CYP3a4 inhibitor screening kit, cyp3a inhibitor kit, cytochrome inhibitor screening, screen cyp3a inhibitors, study cytochrome P450 3A inhibitors, characterize cyp3a4 inhibitors, Cyt P450 inhibitor, Cytochrome P450 ligand screening kit, Cyp3a ligand screening kit, CYP3A4 inhibitor screening, screen inhibitors of CYP enzymes, study cytochrome P450 inhibitors, characterize CYP inhibitors, Cytochrome P450 ligands, cytochrome P450 3A4, June-AK-15? Detection method - Fluorescence (Ex/Em 535/587 nm) ? Species reactivity - Eukaryotes ? Applications - ? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP3A4 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP3A4. ? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP3A4 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP3A4. Samples containing drugs, inhibitors or ligands (compounds that can interact and affect CYP3A activity)